Healthcare provider profile · identity verified

Adam D Keesling, MD

Family Practice · ARKANSAS CITY, KS · NPI 1881956001

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	389	108
Levothyroxine Sodium	Levothyroxine Sodium	252	61
Rosuvastatin Calcium	Rosuvastatin Calcium	252	61
Amlodipine Besylate	Amlodipine Besylate	201	53
Losartan Potassium	Losartan Potassium	166	47
Pantoprazole Sodium	Pantoprazole Sodium	162	52
Lisinopril	Lisinopril	161	45
Omeprazole	Omeprazole	132	34
Arexvy	Rsvpref3 Antigen/As01e/Pf	128	128
Escitalopram Oxalate	Escitalopram Oxalate	118	31
Tamsulosin Hcl	Tamsulosin Hcl	114	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	99	23
Tramadol Hcl	Tramadol Hcl	99	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	98	25
Simvastatin	Simvastatin	92	23
Furosemide	Furosemide	89	26
Gabapentin	Gabapentin	89	29
Alendronate Sodium	Alendronate Sodium	87	23
Allopurinol	Allopurinol	87	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	85	25
Ozempic	Semaglutide	84	suppressed
Cephalexin	Cephalexin	83	64
Metformin Hcl	Metformin Hcl	82	21
Hydrochlorothiazide	Hydrochlorothiazide	80	20
Metformin Hcl Er	Metformin Hcl	80	21
Meloxicam	Meloxicam	79	30
Montelukast Sodium	Montelukast Sodium	79	22
Potassium Chloride	Potassium Chloride	75	20
Sertraline Hcl	Sertraline Hcl	62	13
Mirtazapine	Mirtazapine	59	14
Albuterol Sulfate Hfa	Albuterol Sulfate	56	28
Amitriptyline Hcl	Amitriptyline Hcl	55	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	54	42
Bupropion Xl	Bupropion Hcl	52	14
Alprazolam	Alprazolam	51	suppressed
Trazodone Hcl	Trazodone Hcl	51	12
Venlafaxine Hcl Er	Venlafaxine Hcl	51	12
Metoprolol Succinate	Metoprolol Succinate	49	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	14
Clopidogrel	Clopidogrel Bisulfate	44	12
Pregabalin	Pregabalin	44	suppressed
Warfarin Sodium	Warfarin Sodium	44	suppressed
Methylprednisolone	Methylprednisolone	43	36
Mounjaro	Tirzepatide	39	11
Diclofenac Sodium	Diclofenac Sodium	38	11
Tizanidine Hcl	Tizanidine Hcl	38	suppressed
Amoxicillin	Amoxicillin	37	34
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	suppressed
Azithromycin	Azithromycin	36	32
Finasteride	Finasteride	36	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	suppressed
Klor-Con M20	Potassium Chloride	34	15
Pravastatin Sodium	Pravastatin Sodium	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Donepezil Hcl	Donepezil Hcl	33	11
Fluticasone Propionate	Fluticasone Propionate	33	suppressed
Lorazepam	Lorazepam	33	16
Metoprolol Tartrate	Metoprolol Tartrate	32	suppressed
Celecoxib	Celecoxib	31	suppressed
Eliquis	Apixaban	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Estradiol	Estradiol	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	11
Prednisone	Prednisone	28	26
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	27	27
Atenolol	Atenolol	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	21
Famotidine	Famotidine	24	suppressed
Valsartan	Valsartan	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	21
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	13
Lovastatin	Lovastatin	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Fluconazole	Fluconazole	18	15
Nystatin	Nystatin	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Cefdinir	Cefdinir	17	16
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	13
Novolog Flexpen	Insulin Aspart	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	11
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	13
Januvia	Sitagliptin Phosphate	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Carvedilol	Carvedilol	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Glipizide	Glipizide	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Vilazodone Hcl	Vilazodone Hcl	12	suppressed
Baclofen	Baclofen	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Estradiol-Norethindrone Acetat	Estradiol/Norethindrone Acet	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error